Table 1.

Patient groups characterization for tumor risk factors and time to direct-acting antiviral agents treatment introduction

Factors	Direct-acting antiviral agents		Not treated with direct-acting antiviral agents
Number of patients	19 (37%)		32 (63%)
Number of SVR	18 (94.7%)		–
Diameter of the tumor [mm]	25.9 (12-46)		29.6 (16-50)
AFP before treatment [mg/dl]	139.2 (2-880)		32.4 (1.7-198)
AFP after treatment [mg/dl]	19.2 (0-122)		11.6 (0-28)
Time from surgery to DAA [days]	326.7 (20-1513)		–
	HCC recurrence (8 cases) 259.6 (20-762)	No HCC recurrence (11 cases) 375.5 (31-1531)

SVR – sustained virological response, AFP – alpha-fetoprotein, HCC – hepatocellular carcinoma, DAA – direct-acting antiviral agent